🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Felicia Cosman

Helen Hayes Hospital

ORCID: 0000-0003-4554-6616

Also affiliated with Columbia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis”.

Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis

Bone(2022)10.1016/j.bone.2022.116618

N/A

0.557DataRank · unranked

12 citations

Jeri W. Nieves, Tony M. Keaveny, Felicia Cosman, Aravinda Ganapathy

Loading modality and age influence teriparatide-induced bone formation in the human femoral neck

Bone(2020)10.1016/j.bone.2020.115373

N/A

0DataRank · unranked

10 citations

Mathias P. Bostrom, David W. Dempster, Jeri W. Nieves, Hua Zhou, Felicia Cosman +1 more

No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

Bone Reports(2020)10.1016/j.bonr.2020.100253

N/A

0DataRank · unranked

10 citations

Paul Roschger, Hua Zhou, Jeri W. Nieves, Mathias P. Bostrom, Felicia Cosman +4 more